Synthesis, antiviral potency, in vitro ADMET, and X-ray structure of potent CD4 mimics as entry inhibitors that target the Phe43 cavity of HIV-1 gp120 F Curreli, YD Kwon, DS Belov, RR Ramesh, AV Kurkin, A Altieri, ... Journal of medicinal chemistry 60 (7), 3124-3153, 2017 | 69 | 2017 |
Structure-based lead optimization to improve antiviral potency and ADMET properties of phenyl-1H-pyrrole-carboxamide entry inhibitors targeted to HIV-1 gp120 F Curreli, DS Belov, Y Do Kwon, R Ramesh, AM Furimsky, K O'Loughlin, ... European journal of medicinal chemistry 154, 367-391, 2018 | 41 | 2018 |
Design, synthesis and evaluation of small molecule CD4-mimics as entry inhibitors possessing broad spectrum anti-HIV-1 activity F Curreli, DS Belov, RR Ramesh, N Patel, A Altieri, AV Kurkin, ... Bioorganic & medicinal chemistry 24 (22), 5988-6003, 2016 | 27 | 2016 |
Synthesis, Antiviral Activity, and Structure–Activity Relationship of 1, 3‐Benzodioxolyl Pyrrole‐Based Entry Inhibitors Targeting the Phe43 Cavity in HIV‐1 gp120 F Curreli, DS Belov, S Ahmed, RR Ramesh, AV Kurkin, A Altieri, ... ChemMedChem 13 (21), 2332-2348, 2018 | 18 | 2018 |
Synthesis of 5-arylpyrrole-2-carboxylic acids as key intermediates for NBD series HIV-1 entry inhibitors DS Belov, VN Ivanov, F Curreli, AV Kurkin, A Altieri, AK Debnath Synthesis 49 (16), 3692-3699, 2017 | 16 | 2017 |